Baillie Gifford - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 238 filers reported holding BLUEBIRD BIO INC in Q1 2021. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2023$2,735
-54.0%
8600.0%0.00%
Q4 2022$5,951
+19.0%
8600.0%0.00%
Q3 2022$5,000
+25.0%
8600.0%0.00%
Q2 2022$4,0000.0%8600.0%0.00%
Q1 2022$4,000
-55.6%
8600.0%0.00%
Q4 2021$9,000
-43.8%
8600.0%0.00%
Q3 2021$16,000
-42.9%
8600.0%0.00%
Q2 2021$28,0000.0%860
-5.8%
0.00%
Q1 2021$28,000
-97.2%
913
-96.1%
0.00%
-100.0%
Q4 2020$1,009,000
-97.4%
23,325
-96.7%
0.00%
-96.2%
Q3 2020$38,146,000
-10.2%
707,068
+1.6%
0.03%
-18.8%
Q2 2020$42,492,000
+32.9%
696,127
+0.1%
0.03%
-8.6%
Q1 2020$31,970,000
-47.6%
695,6080.0%0.04%
-40.7%
Q4 2019$61,039,000
-80.8%
695,608
-79.9%
0.06%
-83.7%
Q3 2019$317,313,000
-40.9%
3,455,816
-18.2%
0.36%
-36.7%
Q2 2019$537,233,000
-23.8%
4,223,534
-5.7%
0.57%
-26.1%
Q1 2019$704,697,000
+56.8%
4,479,101
-1.1%
0.77%
+32.0%
Q4 2018$449,289,000
-33.7%
4,529,123
-2.5%
0.58%
-20.2%
Q3 2018$677,956,000
-10.8%
4,643,528
-4.1%
0.73%
-10.7%
Q2 2018$760,171,000
-11.7%
4,843,399
-3.9%
0.82%
-18.8%
Q1 2018$860,932,000
-6.8%
5,042,067
-2.8%
1.01%
-12.1%
Q4 2017$924,061,000
+26.5%
5,188,435
-2.5%
1.15%
+24.2%
Q3 2017$730,730,000
+28.8%
5,320,202
-1.5%
0.92%
+21.2%
Q2 2017$567,339,000
+19.9%
5,400,658
+3.8%
0.76%
+10.9%
Q1 2017$473,102,000
+48.5%
5,204,633
+0.8%
0.69%
+31.3%
Q4 2016$318,647,000
-6.0%
5,164,467
+3.3%
0.52%
-1.1%
Q3 2016$338,821,000
+54.9%
4,998,833
-1.1%
0.53%
+35.9%
Q2 2016$218,795,000
+3.4%
5,054,175
+1.5%
0.39%
+4.8%
Q1 2016$211,549,000
-32.5%
4,977,637
+1.9%
0.37%
-31.7%
Q4 2015$313,607,000
-23.2%
4,883,321
+2.1%
0.54%
-31.9%
Q3 2015$408,534,000
-34.4%
4,783,704
+29.4%
0.80%
-28.5%
Q2 2015$622,533,000
+301.5%
3,697,412
+188.0%
1.12%
+281.9%
Q1 2015$155,064,0001,283,9620.29%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,282,827$13,019,7941.84%
Birchview Capital, LP 455,200$1,383,8081.18%
PFM Health Sciences, LP 6,040,934$18,364,4390.86%
Lion Point Capital, LP 531,256$1,615,0180.72%
Endurant Capital Management LP 251,785$765,4260.69%
Bleichroeder LP 900,000$2,736,0000.67%
Connacht Asset Management LP 31,634$96,1670.57%
Granahan Investment Management 5,137,778$15,618,8450.56%
Frazier Life Sciences Management, L.P. 1,709,907$5,198,1170.34%
Contrarius Investment Management Ltd 1,308,002$3,9760.22%
View complete list of BLUEBIRD BIO INC shareholders